# Topical Nitro or Placebo Pre-Cath

Study · id `cardio:ct-nct06289946` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06289946](<https://clinicaltrials.gov/study/NCT06289946>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06289946

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 256 participants.

## Technical summary

Registry record NCT06289946. Randomized; double masking; primary purpose treatment. Start 2024-03-01 (anticipated); primary completion 2025-03-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 256 participants (planned count; ClinicalTrials.gov record NCT06289946, source copy `cardio:ctgov-nct06289946-2024-03-04`, retrieved 2026-10-26)
- Planned start: 2024-03-01 (anticipated) (ClinicalTrials.gov record NCT06289946, source copy `cardio:ctgov-nct06289946-2024-03-04`, retrieved 2026-10-26)
- Primary completion: 2025-03-01 (anticipated) (ClinicalTrials.gov record NCT06289946, source copy `cardio:ctgov-nct06289946-2024-03-04`, retrieved 2026-10-26)
- Completion: 2025-03-31 (anticipated) (ClinicalTrials.gov record NCT06289946, source copy `cardio:ctgov-nct06289946-2024-03-04`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06289946-2024-03-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Topical Nitro or Placebo Pre-Cath
- Condition: Coronary Artery Disease
- Intervention (Drug): NitroBid
- Intervention (Drug): Placebo
- Lead sponsor: Thomas Jefferson University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Thomas Jefferson University (`cardio:org-thomas-jefferson-university`)

## Provenance

Content hash: 7ad0406841a44085230711208f2288065f680441f1d55399b7d310787dd3c888
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
